Evaluation of the Effect of Mechanical Ventilation on the Pharmacokinetic Parameters of Vancomycin in Intensive Care Patients: A Prospective Cohort Study
Authors:
Open Access
- 1 February 2026
- journal article
- Published by Wolters Kluwer Health in Journal of Research in Pharmacy Practice
- Vol. 15 (1)
Abstract
Objective: Intensive care unit (ICU) patients on mechanical ventilation, in particular, may experience changes in pharmacokinetics due to alterations in cardiac output and organ blood flow. This study aims to evaluate the effects of mechanical ventilation on the steady-state pharmacokinetic changes of vancomycin. Methods: In this prospective cohort study, eligible patients were enrolled into either the ventilated or non-ventilated group. Demographic and clinical data were gathered, and peak and trough blood samples were collected to measure their levels. Additional pharmacokinetic parameters were calculated using appropriate formulas. Findings: A total of 39 ICU patients were enrolled in the final analysis. Of these, 32 matched patients were divided into two equal groups: ventilated and nonventilated. None of the pharmacokinetic parameters, including peak plasma concentration ( P = 0.878), trough plasma concentration ( P = 0.437), volume of distribution ( P = 0.468), K ( P = 0.234), t ½ ( P = 0.266), clearance ( P = 0.709), and daily area under the curve ( P = 0.418), were significantly different between the two groups. Bivariate correlation analysis showed a significant correlation between estimated glomerular filtration rate, acute physiology and chronic health evaluation II score, and C-reactive protein (CRP) level with vancomycin pharmacokinetic parameters. Furthermore, significant effects of augmented renal clearance (ARC) on vancomycin pharmacokinetics were determined. Conclusion: The key finding of this study was that ARC significantly impacted vancomycin serum levels, resulting in subtherapeutic concentrations in 23.1% of patients. High CRP levels also significantly correlated with increased vancomycin distribution volume, emphasizing the role of inflammation. These findings underscore the importance of personalized vancomycin dosing, taking into account factors such as ARC and inflammation, to improve patient outcomes. However, due to the small sample size, further studies with larger cohorts are necessary.Keywords
This publication has 45 references indexed in Scilit:
- Management of methicillin-resistant Staphylococcus aureus bloodstream infections: a comprehensive narrative review of available evidence focusing on current controversies and the challenges aheadExpert Review of Anti-infective Therapy, 2025
- What every intensivist should know about augmented renal clearance (ARC)Journal of Critical Care, 2024
- Pharmacokinetic Alterations Associated with Critical IllnessClinical Pharmacokinetics, 2023
- Physiological and Pathophysiological Consequences of Mechanical VentilationSeminars in Respiratory and Critical Care Medicine, 2022
- The cardiovascular effects of positive pressure ventilationBJA Education, 2021
- Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulationsPharmacology Research & Perspectives, 2018
- Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With SepsisClinical Therapeutics, 2016
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continentsThe Lancet, 2016
- Clinical implications of antibiotic pharmacokinetic principles in the critically illIntensive Care Medicine, 2013
- Changes in gentamicin pharmacokinetic profiles induced by mechanical ventilationEuropean Journal of Clinical Pharmacology, 1991